vs
SUTRO BIOPHARMA, INC.（STRO）与VALUE LINE INC（VALU）财务数据对比。点击上方公司名可切换其他公司
SUTRO BIOPHARMA, INC.的季度营收约是VALUE LINE INC的1.4倍（$11.6M vs $8.3M），VALUE LINE INC同比增速更快（-7.7% vs -21.4%），过去两年VALUE LINE INC的营收复合增速更高（-4.1% vs -5.4%）
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
价值线公司是一家总部位于纽约的上市投资研究与金融出版企业，由阿诺德·伯恩哈德于1931年创立。该公司最为人熟知的业务是出版《价值线投资调查》，这份股票分析刊物跟踪覆盖约1700只上市个股的行情与研究。
STRO vs VALU — 直观对比
营收规模更大
STRO
是对方的1.4倍
$8.3M
营收增速更快
VALU
高出13.6%
-21.4%
两年增速更快
VALU
近两年复合增速
-5.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $11.6M | $8.3M |
| 净利润 | — | $5.9M |
| 毛利率 | — | — |
| 营业利润率 | — | 12.1% |
| 净利率 | — | 71.4% |
| 营收同比 | -21.4% | -7.7% |
| 净利润同比 | 35.4% | 14.5% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收STROVALU
| Q1 26 | — | $8.3M | ||
| Q4 25 | $11.6M | $8.6M | ||
| Q3 25 | $9.7M | $8.6M | ||
| Q2 25 | $63.7M | $8.4M | ||
| Q1 25 | $17.4M | $9.0M | ||
| Q4 24 | $14.8M | $8.8M | ||
| Q3 24 | $8.5M | $8.9M | ||
| Q2 24 | $25.7M | $9.0M |
净利润STROVALU
| Q1 26 | — | $5.9M | ||
| Q4 25 | — | $5.7M | ||
| Q3 25 | $-56.9M | $6.5M | ||
| Q2 25 | $-11.5M | $4.0M | ||
| Q1 25 | $-76.0M | $5.2M | ||
| Q4 24 | $-72.4M | $5.7M | ||
| Q3 24 | $-48.8M | $5.9M | ||
| Q2 24 | $-48.0M | $4.8M |
营业利润率STROVALU
| Q1 26 | — | 12.1% | ||
| Q4 25 | — | 17.7% | ||
| Q3 25 | -499.9% | 17.4% | ||
| Q2 25 | -5.2% | 9.9% | ||
| Q1 25 | -393.8% | 17.4% | ||
| Q4 24 | -440.7% | 19.7% | ||
| Q3 24 | -797.2% | 20.8% | ||
| Q2 24 | -189.4% | 16.5% |
净利率STROVALU
| Q1 26 | — | 71.4% | ||
| Q4 25 | — | 66.4% | ||
| Q3 25 | -586.6% | 75.1% | ||
| Q2 25 | -18.0% | 47.1% | ||
| Q1 25 | -436.6% | 57.6% | ||
| Q4 24 | -489.2% | 64.3% | ||
| Q3 24 | -572.6% | 66.3% | ||
| Q2 24 | -186.8% | 53.1% |
每股收益（稀释后）STROVALU
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $-0.67 | — | ||
| Q2 25 | $-0.14 | — | ||
| Q1 25 | $-0.91 | — | ||
| Q4 24 | $-27.63 | — | ||
| Q3 24 | $-0.59 | — | ||
| Q2 24 | $-0.59 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $141.4M | $92.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-132.5M | $107.8M |
| 总资产 | $173.8M | $151.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资STROVALU
| Q1 26 | — | $92.5M | ||
| Q4 25 | $141.4M | $86.6M | ||
| Q3 25 | $167.6M | $33.7M | ||
| Q2 25 | $205.1M | $67.7M | ||
| Q1 25 | $249.0M | $52.8M | ||
| Q4 24 | $316.9M | $22.3M | ||
| Q3 24 | $388.3M | $30.9M | ||
| Q2 24 | $375.6M | $4.4M |
股东权益STROVALU
| Q1 26 | — | $107.8M | ||
| Q4 25 | $-132.5M | $105.5M | ||
| Q3 25 | $-87.3M | $103.0M | ||
| Q2 25 | $-32.1M | $99.7M | ||
| Q1 25 | $-25.8M | $99.0M | ||
| Q4 24 | $44.6M | $96.7M | ||
| Q3 24 | $111.2M | $93.9M | ||
| Q2 24 | $152.2M | $90.8M |
总资产STROVALU
| Q1 26 | — | $151.0M | ||
| Q4 25 | $173.8M | $147.9M | ||
| Q3 25 | $209.7M | $148.2M | ||
| Q2 25 | $262.4M | $144.5M | ||
| Q1 25 | $321.4M | $143.6M | ||
| Q4 24 | $387.2M | $140.0M | ||
| Q3 24 | $451.8M | $138.6M | ||
| Q2 24 | $489.0M | $136.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-177.2M | $5.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | 0.89× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流STROVALU
| Q1 26 | — | $5.3M | ||
| Q4 25 | $-177.2M | $3.0M | ||
| Q3 25 | $-38.2M | $5.6M | ||
| Q2 25 | $-44.7M | $20.2M | ||
| Q1 25 | $-67.9M | $6.9M | ||
| Q4 24 | $-71.7M | $3.1M | ||
| Q3 24 | $-64.5M | $4.8M | ||
| Q2 24 | $9.5M | $17.9M |
自由现金流STROVALU
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $20.1M | ||
| Q1 25 | — | $6.8M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | — | $4.8M | ||
| Q2 24 | — | $17.9M |
自由现金流率STROVALU
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 239.2% | ||
| Q1 25 | — | 75.3% | ||
| Q4 24 | — | 34.1% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 199.0% |
资本支出强度STROVALU
| Q1 26 | — | 0.0% | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.2% |
现金转化率STROVALU
| Q1 26 | — | 0.89× | ||
| Q4 25 | — | 0.52× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 5.12× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | — | 0.54× | ||
| Q3 24 | — | 0.81× | ||
| Q2 24 | — | 3.75× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
